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Abstract
Background: The rollout of antiretroviral therapy in sub-Saharan Africa has brought lifesaving treatment to millions of HIV-
infected individuals. Treatment is lifelong, however, and to continue to benefit, patients must remain in care. Despite this,
systematic investigations of retention have repeatedly documented high rates of loss to follow-up from HIV treatment
programs. This paper introduces an explanation for missed clinic visits and subsequent disengagement among patients
enrolled in HIV treatment and care programs in Africa.
Methods and Findings: Eight-hundred-ninety patients enrolled in HIV treatment programs in Jos, Nigeria; Dar es Salaam,
Tanzania; and Mbarara, Uganda who had extended absences from care were tracked for qualitative research interviews.
Two-hundred-eighty-seven were located, and 91 took part in the study. Interview data were inductively analyzed to identify
reasons for missed visits and to assemble them into a broader explanation of how missed visits may develop into
disengagement. Findings reveal unintentional and intentional reasons for missing, along with reluctance to return to care
following an absence. Disengagement is interpreted as a process through which missed visits and ensuing reluctance to
return over time erode patients’ subjective sense of connectedness to care.
Conclusions: Missed visits are inevitable over a lifelong course of HIV care. Efforts to prevent missed clinic visits combined
with moves to minimize barriers to re-entry into care are more likely than either approach alone to keep missed visits from
turning into long-term disengagement.
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The rollout of antiretroviral therapy (ART) in sub-Saharan
Africa has brought lifesaving treatment to millions of HIV-infected
individuals. To continue to benefit from therapy, however,
patients must remain in care. Ensuring long-term retention in
care and treatment for HIV/AIDS has proven challenging in
resource-scarce settings [1–5]. Tracking studies in which patients
lost to follow-up are sought in the community to ascertain
outcomes suggest that 20%–80% of patients ‘‘lost’’ but alive are no
longer in care [6,7]. Previous research by Geng et al. [8] using
tracking data to estimate outcomes for a large clinic population
indicated that approximately one in six patients taking ART were
not in care after 2 y. Understanding disengagement from care is
essential to improving retention and, thus, long-term outcomes of
treatment.
The existing literature on barriers to ART adherence sheds
considerable light on the retention problem. Since adherence
means not only following dosing regimens but also being able to
refill prescriptions, and since prescriptions are refilled as part of
routine follow-up visits in Africa, barriers to adherence and
retention overlap. Travel distance to clinic sites and associated
costs, stigma and fear of disclosure, competing demands for scarce
resources, religious and cultural beliefs, and unanticipated
obligations and events (e.g., attending a family funeral) are key
adherence barriers identified through previous research that also
bear upon retention [9–14]. Motivation stemming from improved
health following ART initiation, material and emotional support
from others, and the promise of increased longevity are
overlapping facilitators [15,16].
As retention research develops, a number of patterns are
emerging to suggest factors shaping disengagement. Disengage-
ment rates appear particularly high for patients who have not yet
initiated ART [17–23], and lower in decentralized care sites [24–
27]. There is some evidence that younger patients, men, pregnant
women, and individuals who have not disclosed their HIV status
disappear from care more frequently [23,28–32].
A wide variety of contributors to missed visits have been cited in
patients’ own accounts. Patient-reported barriers include travel
distance to clinic, and associated time and expense; traveling/
being away from home on the visit date; fear of disclosure; stigma;
dissatisfaction with care; improved health; discouragement and the
desire to ‘‘give up’’; ‘‘return to normal life’’; and a relatively low
perception of risk associated with HIV [33–40]. Psychological
facilitators have also been suggested, among them motivation, high
perceived risk associated with HIV, and a sense of self-efficacy
(feeling capable of meeting treatment requirements) [35,41]. The
number of studies with data on reasons for missed visits collected
from patients has grown rapidly in recent years. In most cases, these
data are reported simply as lists of reasons patient participants have
provided, stopping short of deeper analysis.
For a more integrated, interpretive approach, we may look to
the ‘‘meta-ethnography’’ by Merten et al. [40], which reviewed
existing qualitative studies and integrated data to propose an
explanatory ‘‘line of argument’’. Drawing inductively upon results
from 31 primary studies, the authors highlighted the importance
of social processes in mediating ART adherence and retention
in HIV care in Africa. Patients’ ‘‘social integrity’’ and ‘‘social
careers’’—both of which refer to negotiation of social relationships
in the context of ART treatment—were offered as concepts to
clarify the social processes involved.
The goals of our research are also explanatory. Our conceptual
starting point is a social contextual explanation of ART adherence
in Africa centering on patients’ sense of social responsibility as a
motivating factor. This sense of responsibility is seen as a
reciprocal response to material and emotional help from family,
treatment supporters, health care providers, and others without
which continued adherence to ART and to clinic follow-up
appointments would not be possible. As recipients of ongoing
adherence help, individuals taking ART feel a responsibility to
helpers to succeed at therapy. Success thus becomes both a social
responsibility and a means of ensuring help continues to be
available into the future [42].
This qualitative, patient-centered research aimed to help
explain missed clinic visits and subsequent disengagement from
HIV/AIDS treatment and care in sub-Saharan Africa. The study
took place in three African countries—Nigeria, Tanzania, and
Uganda—and had two objectives. First, we set out to inductively
identify and characterize in depth reasons for missed visits from
the perspectives of patients. Second, we worked to assemble
identified reasons into a broader explanation of missed visits and
disengagement from care.
Methods
Country Settings and Clinical Study Sites
Tanzania, Uganda, and Nigeria represent diverse geographic
and cultural settings. However, all three countries have general-
ized HIV epidemics in which women are disproportionately
affected [43]. Characteristics of the epidemics vary across
countries, but all three have seen prevalence rates drop with
global scale-up of free ART. Huge health gains have resulted from
the scale-up effort, yet more than half of eligible adults remain
without access to therapy. Recent estimates place the number of
adults living with HIV/AIDS at 1–1.5 million in Tanzania and
Uganda, and at 3.3 million in Nigeria (see Table 1). The difference
in numbers reflects population differences, at least in part. At
approximately 160 million, Nigeria’s population is the largest of all
African countries. The number of adults living with HIV/AIDS in
Nigeria is reported to be the third highest in the world [44].
Participating clinical study sites were the Jos University
Teaching Hospital (JUTH) AIDS Prevention Initiative in Nigeria
HIV/AIDS Clinic (APIN Clinic) in Jos, Nigeria; the Mwananya-
mala Hospital HIV/AIDS Care and Treatment Center in Dar es
Salaam, Tanzania; and the Mbarara Regional Referral Hospital
Immune Suppression Syndrome Clinic (ISS Clinic) in Mbarara,
Uganda. All three are large clinics providing comprehensive
treatment, care, and support services for patients with HIV/AIDS.
Physicians, nurses, counselors, and pharmacists provide services to
patients, supported by technical, administrative, and ancillary
staff. The total number of direct care staff ranges widely across the
sites, from fewer than 30 to more than 70 (full- and part-time). The
JUTH APIN Clinic serves the city of Jos, with a population of
approximately 1.5 million, and the surrounding central plateau
region of Nigeria. Mwananyamala Hospital HIV/AIDS Care and
Treatment Center serves the Kinondoni Municipality of Dar es
Salaam, Tanzania’s largest city, numbering about 4 million
people. The ISS Clinic serves the Mbarara District of southwest
Uganda and parts of neighboring districts (approximately 3 million
people). Additional information about participating clinical study
sites appears in Table 2.
Patient Tracking for Research and Clinical Care
With the identification of loss to follow-up as a threat to the
long-term success of ART scale-up in Africa, patient tracking has
been increasingly relied upon by researchers as a means of
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[7,8,37,38]. At the same time, local treatment program planners
and health care practitioners have independently developed
patient tracking as part of HIV clinical care. For clinical purposes,
tracking is used to encourage retention and to contact patients
who need to be seen outside of regular appointment schedules.
Clinical trackers are trained health care workers or volunteers.
Permission for tracking is requested from patients at enrollment in
care. In-person patient tracking is a culturally meaningful clinical
strategy for making contact with patients in the absence of highly
developed telecommunications systems. As mobile phones become
more widely available, telephone tracking is replacing the in-
person approach.
Clinical trackers travel outside clinics to locate patients in the
community. From lists of patients to be tracked, trackers organize
itineraries for in-person tracking and lists of individuals to be
followed up by telephone, then attempt to make contact. The
tracking programs at the three clinical sites participating in this
study differed in size, mode of transport, reliance on phone versus
in-person tracking, and distance traveled to locate patients.
Differences reflected distinctions in clinic policy and/or local
practice. Trackers at all three sites were paid and received training
in HIV treatment, ethical practice, and tracking procedures.
Sampling and Recruitment
The sample for this study was generated using clinic tracking
lists. The lists identified adult patients aged 18 y and older who
were (1) enrolled in care, (2) had missed a regularly scheduled
follow-up visit, and (3) had not subsequently returned to the clinic
for 3 mo or more. A 3-mo period of absence was chosen following
the practices of participating clinics for identifying patients to be
tracked. Lists of persons fulfilling these criteria were generated by
data managers at the sites from clinic databases and forwarded to
clinic trackers for follow-up. When an individual was contacted
through clinic tracking, and after standard clinic tracking
procedures had been completed, trackers briefly introduced the
research using an institutional-review-board-approved script, and
requested permission for follow-up by study research assistants.
Individuals giving permission were then recontacted by research
assistants, who described the study in detail, answered questions,
and enrolled those who expressed interest in participating. Thus,
individuals participating in the study met the following inclusion
criteria: (1) were absent from the clinic for 3 mo or more, (2) were
tracked and contacted by clinic trackers, (3) gave permission for
additional follow-up by study research assistants, (4) were
successfully recontacted by study research assistants, and (5) were
able and willing to provide informed consent.
Ethics
This study was approved by the Harvard Medical School
Committee on Human Studies, Boston, Massachusetts; the JUTH
Institutional Health Ethical Research Committee, Jos, Nigeria; the
Muhimbili University of Health and Allied Sciences Senate
Research and Publications Committee, Dar es Salaam, Tanzania;
the Mbarara University of Science and Technology Institutional
Review Committee, Mbarara, Uganda; and the Uganda National
Council on Science and Technology, Kampala, Uganda. All study
participants provided written informed consent. Compensation in
the form of cash and/or reimbursement for travel to interview
locations was provided. Amounts and forms of compensation were
Table 1. Characteristics of country settings [63–74].
Characteristic Country
Nigeria Uganda Tanzania
Population 158,423,000 (2010) 33,425,000 (2010) 44,841,000 (2010)
HIV prevalence before ART scale-up 4.5% (1998) 8.3% (1999) 8.0% (1998)
Year free ART became available 2006 2004 2004
HIV prevalence after ART scale-up 3.6% [3.3%–4%] (2009) 6.5% [5.9%–6.9%] (2009) 5.6% [5.3%–6.1%] (2009)
Number of adults on ART 359,200 (2010) 248,200 (2010) 258,100 (2010)
Percent eligible receiving ART 31.0% (2009) 47.0% (2011) 50.0% (2010)
Number of adults living with HIV 3.3 million [2.9–3.6 million] (2009) 1.2 million [1.1–1.3 million] (2009) 1.4 million [1.3–1.5 million] (2009)
95% CIs given in brackets; year given in parentheses.
doi:10.1371/journal.pmed.1001369.t001
Table 2. Characteristics of participating study sites.
Characteristic
APIN Clinic
(Jos, Nigeria)
Mwananyamala Hospital HIV/AIDS
Care and Treatment Center
(Dar es Salaam, Tanzania)
ISS Clinic
(Mbarara, Uganda)
Geographic setting Urban Urban Peri-urban and rural
Size of population served 22 million 4 million 3 million
Year opened 2002 2004 1998
Total adults enrolled in HIV/AIDS care 17,139 16,107 21,149
Total adults currently followed 10,532 5,478 8,808
Adults currently followed on ART 8,854 3,930 7,140
doi:10.1371/journal.pmed.1001369.t002
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boards at participating sites.
Data Collection
Data were collected from 15 January 2010 through 30 March
2012 using in-depth in-person interviews with enrolled patient
participants. Consistent with an inductive approach, interviews
were designed to be flexible, following a general, topic-oriented
structure. Topics were selected to address the goals of the research
and included the following: (1) experiences of care at the clinic, (2)
experiences of tracking, and (3) circumstances of missed appoint-
ments. Interviews sought to elicit detailed accounts of actual
experiences of interviewees from their points of view. They were
conducted by trained research assistants in each of the three
countries in local languages, and were audio-recorded with
permission. They took place in private locations—at patients’
homes or at other convenient places of their choosing—and lasted
approximately one hour.
Data Preparation
Upon completion of each interview, interviewers produced a
complete transcript in English from local language audio-
recordings. Each transcript was reviewed for quality by M. A.
W. Interviewers made additions and corrections to transcripts as
indicated by the quality review. The transcripts constituted the
study data.
Data Analysis
Analysis of data aimed to characterize patients’ reasons for
missing clinic visits and to represent them as descriptive categories.
An inductive approach to concept development centering on
category construction and informed by grounded theory method-
ology [45,46] was used to carry out the analysis. Analysis began
with repeated review of interview transcripts to identify sections of
text illuminating reasons for missing clinic visits. These sections of
text were displayed in matrices to reduce the data and facilitate
identification of content similarities or patterns. Sections of text
determined to be similar in content were grouped and assigned
provisional labels to form an initial set of ‘‘reason categories.’’ The
initial category set was then reviewed to confirm that labels
accurately reflected corresponding sections of text. Labels were
revised as necessary to strengthen correspondences and improve
precision. Illustrative quotes were retrieved from interview
transcripts. Multiple authors participated in this process. Dis-
agreements and inconsistencies arising in the analytic process were
resolved through discussion. Data from the three sites were
analyzed separately.
Once the categories were formulated, they were examined
interpretively for broader underlying dimensions and relationships
to each other. This interpretive analysis allowed us to move
beyond a listing of individual reasons for missing clinic appoint-
ments toward a larger, more integrated explanation, and to
highlight previously underemphasized aspects of the problem.
Categories were then further grouped to represent ‘‘unintentional’’
versus ‘‘intentional’’ reasons for missing appointments and were
loosely arranged in time sequence. Of course, other interpretations
are possible. Our goal was to advance thinking and research on
disengagement from HIV care in sub-Saharan Africa by proposing
new conceptualizations suggested by qualitative data.
Results
Outcomes of Tracking
Eight-hundred-ninety patients were tracked at the three sites as
part of recruitment. Two-hundred-eighty-seven were located, and
91 ultimately took part in the study (see Table 3). Of the 91
participants, 76 were being prescribed ART; 15 had not initiated
treatment. Length of time out of care varied widely across the
sample of participants. Reasons for not participating in the study
among located patients included the following: (1) refusal to give
permission for follow-up contact for research, (2) denial of HIV-
positive status to trackers, (3) fear of disclosure of HIV status as a
result of research participation, and (4) preference for remaining
uninvolved in any further HIV-focused activity (treatment or
research). Of 603 patients tracked but not located, 211 (35%) were
reported dead, 144 (24%) had moved, and 79 (13%) were traveling
away from home at the time of tracking visits. No information
could be obtained for the remainder.
Characteristics of Interviewees
The average age of patient interviewees was 36 years. Almost
60% were women; 62% were Christian. On average, they had a
little less than 10 y of education. Three-quarters of interviewees
reported being employed. Median reported travel time to clinic
was about 45 min. Nigerian participants had more years of
schooling than Ugandan or Tanzanian participants, and were
more likely to be employed than Tanzanian participants. Travel
time to clinic was longest in Uganda. Characteristics of patient
interviewees are detailed in Table 4.
Reasons for Missing Visits
Core terms used in the discourse on retention in HIV treatment
and care reflect the evolution of research and thinking on the
topic, while pointing to one or another potential source of
retention problems. ‘‘Loss to follow-up’’ connotes clinics’ difficul-
ties in keeping track of patients, while patient-centered terms—the
currently preferred ‘‘disengagement’’ or the African term
‘‘defaulter’’—imply that missed visits result from patient choice.
In contrast, it was the unintentional origins of missed visits that stood
out among our study participants.
Table 3. Study tracking activities and outcomes.
Site
Number of Trackers
Participating
Tracking Period for
Study Recruitment
Number of Patients
Tracked
Number of Patients
Located (Percent)
Number of Patients
Enrolled
Jos, Nigeria 3 18 mo 254 140 (55%) 40
Dar es Salaam, Tanzania 19 6 mo 208 46 (22%) 20
Mbarara, Uganda 2 17 mo 428 101 (24%) 31
Of the 140 people located in Jos, 17 (12%) were tracked by home visit only (no phone). In Mbarara and Dar es Salaam, the large majority of people were tracked by
home visit only.
doi:10.1371/journal.pmed.1001369.t003
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time.Whendemandsstemmedfromculturalandfamilyobligations,
or economic requirements—e.g., caring for a sick family member in
a distant location,travelingforwork, attendinga relative’sfuneral in
another town—they took precedence over keeping clinic appoint-
ments. The following interview excerpt illustrates this:
I went to the village in December and when it was time to come back
before my appointment of January 3, 2011, I was not able to come
back because I lost a brother. A few days after losing my brother, I lost
another relative and so I stayed in the village. I had planned to come
back on January 1, since my clinic appointment was for January 3, but
I did not come back. [Female, age 27]
Plans were routinely upended by unexpected events, another
source of unintentional absences. Accidents, vehicle breakdowns,
and other travel delays meant that individuals who had traveled
but planned to return before their clinic visit date were stranded
away from home, as in the following case:
What caused me not to come to the clinic was that I lost my father.
When he died, I went to [name of town] for the burial and the money
that I had taken with me ran out. And so I had to first stay there to
make some more to facilitate my return. When I was able to return to
my home, I failed to get the money for transport to the hospital and so I
started working to be able to earn the amount enough to facilitate my
transport fare. [Male, age 40]
Encounters with violence were obstacles for some patients. Lack
of support from family and community in the form of failure to
provide transport funds or of active opposition to care led to
unintentional absences for some interviewees. Errors—misunder-
standing visit dates or forgetting an appointment—were another
unintentional reason for missing.
Some missed visits were intentional. For example, patients
might decide to stop attending a particular clinic as decentraliza-
tion initiatives provided the option of receiving care closer to
home. Patients offered an alternative to long, expensive travel for
care transferred to local facilities. If transfers were not recorded at
the initial care sites, those patients were categorized as ‘‘missing.’’
When patients decided to stop keeping clinic appointments,
the reason could also be dissatisfaction with care. Interviewees
reported objections to clinic policy (e.g., insistence on adherence to
certain days and times of appointments) or some aspect of care
organization(e.g., clinic schedulesthat made forlongwaitingtimes).
Interviewees also complained of harsh treatment by providers.
Harsh treatment typically referred to behavior perceived by
patients to be rude and/or rejecting. For example, interviewees
reported being spoken to ‘‘roughly’’ or feeling that the clinic staff
‘‘didn’t care.’’ ‘‘Shouting’’ and ‘‘bad language’’ were cited. At one
site, references were made to threats that missed visits would result in
being dropped from care. Experiences of harsh treatment left patients
feeling hurt, angry, and humiliated, as the following quotes illustrate:
I felt humiliated. I felt very bad. After receiving the services I was full of
pain. After that incident I didn’t go back to the hospital. I decided to
leave everything and opt for fruits and food…and until now I am not
taking it [ART]. [Male, age 60]
Like my last clinic visit, it became too much. They really looked like they
didn’t care. [Interviewer: Why do you say they looked like they didn’t
care?] When people come to the clinic and go to their [consulting] rooms,
they don’t care about them. There are many patient files piled on their
desks but they just sit there. Or sometimes, they come, look at the files
and then just go their own way. Or sometimes when you enter the
doctor’s room, they start conversing and talking about their own things
while you just sit there and wait for them to finish. [Female, age 27]
…the first day I came, I didn’t know I had to drop my card—hand
card—by the door. So I came in and sat down where my friend said.
The nurse there was so harsh that I didn’t drop my card. She said all
nasty things to me and at a point I said, ‘‘Amen! Let me just go.’’ That
was the first day; that was the first experience. I felt it was not a place
to be. It was like I should just leave the hospital immediately. [Female,
age 35]
They [staff] told me, ‘‘You are late.’’ Now, there are problems people
face. I don’t know how they perceive it but for me this thing is very
difficult. Attending clinic every month is very difficult, because you have
to leave your work, sometimes report [to work] late—reasons like these.
Everyone has problems. They are supposed to solve these problems with
love, not harshly like they do. Until people are afraid of their words—
abusive words. They behave as if we are there to beg for meds. It’s our
right to get the meds. [Female, age 34]
Examined closely, absences are revealed to be less the simple
result of one or another ‘‘reason’’ taken individually, and more the
Table 4. Patient participant interviewee characteristics.
Characteristic All (n=91) Nigeria (n=40) Tanzania (n=20) Uganda (n=31)
Gender female (percent) 59.3 62.5 55.0 58.1
Age (years), mean (SD) 35.9 (8.1) 34.9 (7.4) 39.3 (9.0) 35.0 (8.1)
Religion (percent)
Christian 61.5 52.5 50.0 80.1
Muslim 38.5 47.5 50.0 19.4
Education (years), mean (SD) 9.8 (3.9) 11.9 (3.7) 9.1 (2.8) 7.6 (3.6)
Employment (percent)
Employed 75.8 85.0 55.0 77.4
Unemployed 24.2 15.0 45.0 22.6
Travel time to clinic (minutes), median (IQR) 45 (30–120) 30 (30–60) 30 (30–52.5) 120 (60–180)
IQR, interquartile range; SD, standard deviation.
doi:10.1371/journal.pmed.1001369.t004
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‘‘surface’’ reason is to provide an incomplete, sometimes
inaccurate, account. For a full understanding, one must follow
the events in the chain. An example is the frequently cited
‘‘problem of transport.’’ Transport problems often gloss a much
more complicated set of circumstances. In the following instance,
for example, an interviewee who began his explanation of missed
visits by citing a ‘‘transport problem,’’ went on to reveal more
about what that problem led to and meant:
We fail to get vehicles sometimes. And when you go to look for money for
[a motorcycle taxi] you find you do not have it. So when you miss your
appointment and go to clinic on another day, [the provider] starts
quarreling with you about not having come on the appointed day. And
when you tell that person you got problems, he tells you, ‘‘You should
spend the night on the road.’’ How can I spend the night on the road?
Here I am, having failed to get money for taking me to the hospital and
then I’m supposed to get money to spend the night somewhere and feed
myself? These are some of the problems I have in going to the clinic.
[Male, age 56]
This patient became discouraged and abandoned care—not so
much due to transport difficulties as to the lack of understanding
and accommodation of these difficulties by staff. When located for
this study, he had not been seen for care for 2 y.
In addition to being complex, many obstacles to missed visits
are also transitory. They end, dissipate, or cease to be obstacles as
circumstances change over time. Recognizing this raises the
question, if initial obstacles no longer block clinic attendance, why
don’t patients who miss visits then return? A strong reluctance to
return for care after an absence emerged from the qualitative data.
I was scared to come back to the clinic since a lot of time had already
passed andI mightcome back and they chase me away. [Male, age 40]
I was scared of coming back and them telling me that they will not
accept me because I didn’t come when they told me to. I was wondering
whether they would accept me or not or whether they would scold me.
[Female, age 35]
I was afraid to go back because I didn’t have my card and I stopped
meds for a long time. I was afraid the nurses would yell at me.
[Female, age 35]
Reluctance to Return
Two reasons for this reluctance stand out. The first centers on a
sense of shame articulated by interviewees, who felt a strong sense
of the responsibility that comes with starting ART. Having gained
access to a valuable resource in a resource-scarce environment,
and having been extensively ‘‘educated’’ as to the adherence
commitment access to that resource entails, patients who miss
clinic visits seemed to see themselves as having failed to live up to
their responsibilities when they missed visits and experienced a
treatment lapse. The following quotes illustrate this:
When they accept us and open our files, they tell us this—that when you
start, you should not stop. And if you know you will play with it, then
do not start. So it was because I know I was wrong. That is why I said
I will not be able to return. [Female, age 25]
In fact, when [the tracker] called me, I felt a sense of guilt. This is my
health. I am supposed to be worrying about my health, not somebody else
worrying about my health—you know? [Male, age 46]
Apprehension at anticipated negative responses from care
providers is a second explanation suggested by the data for
reluctance to return. Over time, the distress at perceived poor
treatment prompting patients to miss visits evolves into anticipa-
tion of the painful encounters they see awaiting them upon return.
Interviewees articulated a fear of being ‘‘yelled at,’’ ‘‘abused,’’
and/or ‘‘chased’’ from the clinic should they attempt to resume
treatment after an absence. Rather than face this, they simply
stayed away.
I was afraid to go back because I had stopped meds for a long time and
I didn’t have my [clinic identity] card. I was afraid the nurses would
yell at me…. [Female, age 35]
I did not come back on the date I was given. When the date for me to go
back to the clinic had passed, I feared I would be abused if I went back
past my appointment date. [Female, age 20]
I was scared to come back to the clinic since a lot of time had already
passed and I might come back and they chase me away. [Female, age
20]
The way she told me, ‘‘Why did you miss clinic…despite what
happened, you should have come to the clinic and met other people.’’ I
told her no, I didn’t want to show up because what happened to me [at
the clinic] was still in my heart. If I was treated nicely the situation
would have been different; since I was treated badly I saw the treatment
was meaningless. [Male, age 60]
[Interviewer: The situation of stopping care or treatment at the clinic,
how did that make you feel?] It made me feel bad to see that I had to go
to get meds. Looking at how badly the provider spoke to me, I asked him
how they would be benefiting from my death? I said to myself, ‘‘Let me
leave these things. If I am to die let me do that—die.’’ [Male, age 56]
Reluctance to return, whether originating in shame at having
failed to fulfill a responsibility or apprehension about the
anticipated negative response of providers, signals the erosion of
a subjective sense of connectedness to the idea, processes, and, for
some, the specific site of care. We propose it is this sense of
connectedness, together with family and community support, that
fuels patients’ motivation to consistently overcome economic and
other obstacles to keeping clinic appointments. The lifelong
commitment patients understand themselves to be making in
initiating ART, a sense of caring and expectation of success from
providers, and solidarity with fellow patients all contribute. The
data point to patients’ subjective sense of connectedness to care as
a significant, and to date underappreciated, antecedent of
retention (see Figure 1).
Discussion
This qualitative study reveals the importance of recognizing the
unintentional origins of many missed visits, the often hidden
complexity of reasons for missing, and the ways in which reasons
change over time. A prospective approach to the qualitative data
revealed both the transitory nature of some obstacles to clinic
attendance and a trajectory whereby initial obstacles develop into
reluctance to return. In highlighting these broader dimensions and
identifying ‘‘reluctance to return’’ as an analytic construct, our aim
is to move away from a narrow focus on individual barriers toward
a larger and more integrated explanation.
The prominence of reluctance to return in interviewee accounts
of absences from care signals a potential caution for providers
overseeing initiation of ART. Patient education in clinical settings
for ART initiation in Africa has featured stern warnings about the
lifelong commitment treatment represents, the meaning and
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of lapses. Patients’ feelings of shame at missing visits and fear of
clinic staff’s negative response to absences may indicate just how
seriously they have taken these warnings. Educational efforts
intended to maximize the benefits of ART for patients may
paradoxically be driving some away from care.
How shall we understand the patient complaints of harsh
treatment by staff seen in accounts of reluctance to return? The
qualityofrelationshipsbetween patients and healthcareprovidersin
poor countries has received relatively little research attention.
However, the available literature does clearly indicate that friction
between the two groups, and reports of ‘‘abuse’’ by clinical staff, are
neither specific to HIV/AIDS care nor limited to the sites and
countries represented here [47–53]. Analyses shedding light on the
origins of friction are scarce, but suggest as contributing factors the
overwhelming numbers of patients and the emotional strain of
HIV/AIDScareprovision [54–57],perceived threatsto professional
identity [47,52], and conflicting priorities of patients and staff [51].
Qualitative research in medicine and public health intentionally
aims for in-depth analysis rather than generalizable results.
Nevertheless, single site qualitative studies may reflect limitations in
resources more than dictates of research design. This study was
carriedoutatthreeHIVtreatmentsitesinthreesub-SaharanAfrican
countries. Results reflect commonalities and contrasts across the
three patient participant groups. In all three, visits are missed both
unintentionally and by design, and evolve into reluctance to return.
The specific forms this pattern takes vary, however. The availability
of data from three sites in this study offer the advantage of a broader
baseforanalysis,butdonotallowforformalcross-sitecomparison,as
the qualitative samples were not designed to be representative.
The recent shift in emphasis from increasing access to HIV
treatment to enhancing retention in care has led to a number of
suggestions and changes aimed at reducing absences. Some of
these are structural, e.g., reorganizations of services to make clinic
attendance more convenient and efficient (decentralization,
reduced waiting times, reduced visit frequency) [58]. Others
feature one or another form of community-based support [59,60].
Returning patients to care following an absence has received less
attention as an intervention objective overall.
Yet recent research confirms substantial numbers of lost patients
are alive and can be located [7,8,38,61,62]. This study calls
attention to reluctance to return as a retention barrier. It follows
that interventions designed to address and resolve reluctance
might inspire ‘‘missing’’ patients to return to care [61]. To target
return to care (rather than prevention of missed visits) would be to
bring a harm reduction approach to the retention problem, and to
recognize that, while not optimal, absences will be unavoidable
over a lifetime of treatment. A harm reduction approach would
seek to reduce barriers to re-engagement.
The process through which unintentional and intentional
missed visits evolve into a weakened sense of connectedness,
reluctance to return, and, ultimately, disengagement from care
points to an underlying exchange-based relationship between
health care providers and HIV/AIDS patients receiving care and
ART. In return for access to lifesaving treatment and care, patients
are expected to, and agree to, reciprocate with adherence to both
medication and clinic appointments. The commitment entails a
moral obligation; missed visits are thus a moral failing. Under-
standing the moral dimensions of the treatment relationship makes
sense of patients’ shame, justifies ‘‘scolding’’ by providers, and
explains the common usage of the term ‘‘defaulter’’ (i.e., someone
who fails to repay a debt) to refer to patients who miss clinic
appointments in sub-Saharan Africa.
This study has a number of limitations. First, the study is based
on a convenience sample of patients who could be located through
tracking. Reasons for missed visits among persons who could not
be located are not represented. Social desirability bias and recall
bias may have also resulted in some reasons for missing visits not
appearing in the data. Neither reasons for returning to care
following an absence nor differences across the clinical sites is
examined. A limitation of this analysis qualitatively is that it
reflects only a single perspective: the patient’s perspective. In a
more comprehensive qualitative examination, multiple perspec-
tives on the retention problem would be represented.
Conclusion
International scale-up of treatment and care for HIV/AIDS has
been a resounding public health success. To realize full benefit
from the initiative, high rates of long-term retention are essential.
Retention research focusing on Africa has shed considerable light
on the dimensions of the problem and on reasons for absences
from care as directly reported by patients.
This paper offers a broader and more complete explanation of
disengagement and a new explanatory construct: reluctance to
return. To focus on return is to acknowledge the inevitability of
absences over a lifetime course of treatment for HIV/AIDS. Efforts
to prevent missed clinic visits complemented by moves to minimize
barriers to re-entry into care are more likely than either alone to
keep missed visits from turning into long-term disengagement.
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Background. The human immunodeficiency virus (HIV)
infects cells of the immune system, destroying or impairing
their function. As the infection progresses, the immune
system becomes weaker, and the affected person becomes
more susceptible to life-threatening infections. Over the past
three decades, 25 million people have died from HIV, and
according to the World Health Organization, in 2011, there
were roughly 34.2 million people living with HIV, over 60% of
whom lived in sub-Saharan Africa. Although HIV cannot be
cured, the virus can be suppressed by combination
antiretroviral therapy (ART) consisting of three or more
antiretroviral drugs. ART controls viral replication and
strengthens the immune system, allowing the affected
person to fight off infections. With ART, HIV can be managed
as a chronic disease: people living with HIV can live healthy
lives as long as they take antiretroviral drugs regularly for the
rest of their lives.
Why Was This Study Done? Unfortunately, poor retention
in HIV programs is a huge problem: a large proportion—
30%–60% in some settings in sub-Saharan Africa—of people
starting ART, are lost to follow-up and stop taking treatment.
Few studies have looked in depth at the reasons why people
with HIV in sub-Saharan Africa miss clinic appointments or
even stop coming altogether. So in this study in Tanzania,
Uganda, and Nigeria, the researchers did a qualitative
analysis from the patients’ perspective on the reasons for
missing clinic visits. Qualitative research can use information-
gathering techniques, such as open-ended interviews, to
develop an in-depth understanding of human behavior and
the reasons behind such behavior.
What Did the Researchers Do and Find? The researchers
indentified people to interview by using ‘‘tracking lists’’ from
HIV/AIDS care clinics in the three countries—patient tracking
by clinical trackers is increasingly used as a way to contact
patients who have missed clinic appointments. The research-
ers included people in the study who had been tracked and
contacted by clinic trackers, had been absent from the clinic
for three months or more, and gave consent to be re-
contacted by the researchers. The researchers interviewed
participants, using their local language, on several topics,
including their experiences of care at the clinic and of
tracking, and the circumstances of missed appointments.
The detailed accounts were transcribed, and then the
researchers categorized the reasons for missing appoint-
ments into intentional and unintentional reasons.
Eight-hundred-ninety patients in the three countries were
tracked during the study period, but only 287 were located,
of whom 91 participated in the study. Of the 91 participants,
76 were being prescribed ART, and 15 had not started
treatment. The main unintentional reason for missing clinic
visits was a conflicting demand on the patients’ time, which
was often unexpected and for complex reasons, such as
caring for a dying relative, going to a funeral, or traveling to
work. These reasons were often transient and changed over
time. Intentional reasons were often related to dissatisfaction
with the care received at the clinic, especially ‘‘the harsh
treatment’’ they received from health workers, which
typically referred to behavior perceived by patients to be
rude. For example, participants reported being spoken to
‘‘roughly’’ or feeling that the clinic staff ‘‘didn’t care.’’ Such
behavior made patients feel hurt, humiliated, and angry, and
reluctant to return to the clinic. The researchers found that,
overall, disengagement from care appeared to be a process
through which missed visits and subsequent reluctance to
return over time eroded patients’ sense of connectedness to
care.
What Do These Findings Mean? Absences from care will
be inevitable over a lifetime course of treatment for HIV/
AIDS. These findings indicate that absences may be
unintentional as well as intentional, and that the reasons
are complex and can change over time. Initial reasons for
missing may disappear, leaving patients free, but reluctant,
to return to care. Reasons for reluctance include shame at
having been absent and the anticipation of a negative
response to return from care providers. Patient education for
ART initiation in sub-Saharan Africa often includes stern
warnings about the lifelong commitment beginning ART
represents. Paradoxically, educational efforts intended to
maximize the benefits of ART for patients may be driving
some away from care. Therefore, efforts to prevent missed
clinic visits coupled with strategies to minimize any obstacles
to coming back to care are necessary to keep patients’
missed visits from turning into long-term disengagement
from treatment.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001369.
N This study is further discussed in a PLOS Medicine
Perspective by Edward Mills
N The World Health Organization has the latest data on
access to ART
N The US National Institute of Allergy and Infectious Diseases
has more information on types of ART, and also on
adherence to treatment
N The US Centers for Disease Control and Prevention has
some information about interventions to help improve
adherence
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